American International Group’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,333
| Closed | -$34.8K | – | 2046 |
|
|
2024
Q1 | $34.8K | Sell |
7,333
-64
| -0.9% | -$303 | ﹤0.01% | 2855 |
|
|
2023
Q4 | $31.6K | Buy |
7,397
+295
| +4% | +$1.26K | ﹤0.01% | 2901 |
|
|
2023
Q3 | $21.9K | Buy |
7,102
+2,330
| +49% | +$7.2K | ﹤0.01% | 2977 |
|
|
2023
Q2 | $21.5K | Buy |
+4,772
| New | +$21.5K | ﹤0.01% | 3012 |
|
|
2022
Q2 | – | Sell |
-5,373
| Closed | -$37K | – | 3227 |
|
|
2022
Q1 | $37K | Sell |
5,373
-378
| -7% | -$2.6K | ﹤0.01% | 2936 |
|
|
2021
Q4 | $72K | Sell |
5,751
-172
| -3% | -$2.15K | ﹤0.01% | 2847 |
|
|
2021
Q3 | $185K | Sell |
5,923
-141
| -2% | -$4.4K | ﹤0.01% | 2475 |
|
|
2021
Q2 | $174 | Buy |
6,064
+288
| +5% | +$8 | ﹤0.01% | 2600 |
|
|
2021
Q1 | $250 | Buy |
5,776
+438
| +8% | +$19 | ﹤0.01% | 2249 |
|
|
2020
Q4 | $382 | Buy |
+5,338
| New | +$382 | ﹤0.01% | 1900 |
|